Evidence map›Paper›PMID 31811760›Full record

ArticleIET nanobiotechnology2019

Micro RNA-30b (inhibitor) nanoparticles suppressed the lipopolysaccharide (LPS)-induced acute kidney injury.

Xiang Shao, Suhua Zhang, Ying Tang, Weixin Kong

Open access · bronzeAbstract read
In one paragraph

Article in IET nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiang ShaoDepartment of Kidney Disease, Suzhou Kowloon Hospital Affiliated to Medical College of Shanghai Jiaotong University, Suzhou, Jiangsu 215028, People's Republic of China.
Suhua ZhangDepartment of Kidney Disease, Suzhou Kowloon Hospital Affiliated to Medical College of Shanghai Jiaotong University, Suzhou, Jiangsu 215028, People's Republic of China. suhua.zhang@shsmu.edu.cn.
Ying TangDepartment of Kidney Disease, Suzhou Kowloon Hospital Affiliated to Medical College of Shanghai Jiaotong University, Suzhou, Jiangsu 215028, People's Republic of China.
Weixin KongDepartment of Kidney Disease, Suzhou Kowloon Hospital Affiliated to Medical College of Shanghai Jiaotong University, Suzhou, Jiangsu 215028, People's Republic of China.
Suzhou Kowloon Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main aim of present study is to evaluate the effect of miR-30b on the function of human proximal tubular epithelial cell line HK-2 cells. For this purpose, miRNA was loaded in an ionically cross-linked polysaccharide nanoparticle. The authors have demonstrated the influence of miR-30b mimic and inhibitor in HK-2 cell killing effect. Lipopolysaccharide (LPS) significantly increased the level of inflammatory cytokines of TNF-α, IL-1β and level was further increased with the treatment of PAg-miR mimic consistent with the cell viability assay. Interestingly, PAg-miR inhibitor significantly downregulated the expression of inflammatory cytokines and thereby reduced the inflammation in the body. Western blot analysis showed that LPS induced severe apoptosis of HK-2 cells and the apoptosis was further promoted by the PAg-miR (mimic). In contrast, PAg-miR (inhibitor) alleviated the apoptosis of HK-2 cells as indicated in the significantly reduced levels of Bax and c-Caspase-3 proteins. Overall, miR-30b promoted LPS-induced HK-2 cell inflammatory injury by inducing the apoptosis and by releasing inflammatory cytokines, as well as by impairing autophagy process.

Indexed as

NanoparticlesAcute Kidney InjuryApoptosisAutophagyCell LineCytokinesHumansInflammation MediatorsKidney Tubules, ProximalLipopolysaccharidesMicroRNAsCytokinesInflammation MediatorsLipopolysaccharidesMicroRNAsMIRN30b microRNA, human

Identifiers

PMID31811760
PMCPMC8675982
OpenAlexW2946548254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.